Doxycycline Capsules Recalled Due to Temperature Storage Deviation
Cardinal Healthcare is recalling Doxycycline 100 mg Capsules nationwide due to exposure to temperatures outside labeled storage conditions. No illnesses have been reported.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall without reported illnesses or injuries. The hazard is a manufacturing deviation—temperature exposure—that could affect drug stability and efficacy, but no confirmed harm has been reported.
Plain-English summary
Cardinal Healthcare is recalling Doxycycline Capsules, USP 100 mg, Batch G104819, due to manufacturing deviations. The product was manufactured by Lupin Limited in Nagpur, India for Lupin Pharmaceuticals, Inc.
The recall was issued because products were exposed to temperatures outside the labeled storage conditions. Temperature excursions can potentially affect the stability and efficacy of the antibiotic medication.
This recall affects Doxycycline 100 mg capsules with Batch G104819 distributed nationwide. The affected product is identified by NDC numbers 68180-650, 68180-651, and 68180-652.
The recalled product
- Product
- DOXYCYCLINE (DOXYCYCLINE)
- Brand
- DOXYCYCLINE
- Manufacturer
- CARDINAL HEALTHCARE
- Category
- Drug
- Affected units
- 1
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch G104819
UPCs (2)
- 0368180652083
- 0368180650010
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 42 recalled by CARDINAL HEALTHCARE under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 42 products in this recall →Related recalls
Same brand · DOXYCYCLINE
- ModerateDoxycycline hyclate tablets recalled after stability testing failed dissolution specifications
FDA (Drugs) · 2025-10-15
- ModerateDoxycycline Capsules Recalled for Temperature Control Deviation
FDA (Drugs) · 2022-06-15
- ModeratePD-Rx Recalls Doxycycline Hyclate Tablets for Failed Dissolution Specifications
FDA (Drugs) · 2020-06-03
- SevereSun Pharmaceutical Recalls Doxycycline Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2020-03-25
- ModerateSun Pharmaceutical Recalls Doxycycline Capsules Due to Manufacturing Deviations
FDA (Drugs) · 2020-03-25
Same manufacturer · CARDINAL HEALTHCARE
See all →- HighAlbuterol Sulfate Inhaler Recalled Due to Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- ModerateMeloxicam 15 mg tablets recalled for exposure to improper storage temperatures
FDA (Drugs) · 2024-01-03
- HighPredniSONE Tablets Recalled for Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- HighLow-dose aspirin recall due to improper storage temperature conditions
FDA (Drugs) · 2024-01-03
- HighBumetanide Tablets Recalled for Exposure to Improper Storage Temperatures
FDA (Drugs) · 2024-01-03
Same hazard · temperature excursion
See all →- ModerateCyclophosphamide injection vials recalled after a transportation temperature excursion
FDA (Drugs) · 2025-09-24
- ModerateXolair 75 mg syringes exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateRecombinate antihemophilic factor vials exposed to temperatures outside labeled storage
FDA (Drugs) · 2025-08-13
- ModerateXolair auto-injectors exposed to temperatures outside labeled storage requirements
FDA (Drugs) · 2025-08-13
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30